MAY 25, 2020 11:02 PM PDT

Potential Targets for Alcohol Induced Liver Disease

WRITTEN BY: Nouran Amin

Alcohol-related liver disease (ALD) is a fatal condition targeting more than 150 million people. Part of what makes it deadly is the unavailability of treatment besides a transplant. To address these challenges, researchers at Massachusetts General Hospital (MGH) have uncovered key molecular steps involved in ALD that may provide targets for drug therapy development.

Learn more about ALD:

The groundbreaking findings were published in Proceedings of the National Academy of Sciences (PNAS) and describes how researchers achieved their results by combining RNA sequence analysis of patient liver samples with transgenic mouse studies. Researchers were able to identify two promising potential molecular targets for developing ALD therapeutics-- cGAS and Cx32. The senior author is Suraj J. Patel, MD, PhD, a research fellow in the Department of Medicine.

"Now that we know the key players in this pathway, we finally have drug targets for treatment development," says the lead author on the study is Jay Luther, MD, gastroenterologist and Director of the Mass General Alcohol Liver Center. "Until now, we haven't had any successful leads. Meanwhile, the number of patients has grown."

Before the study, scientists already knew that liver cell (hepatocyte) death in ALD is supported IFN regulatory factor (IRF3) which fuels a strong secondary inflammatory response that affects nearby cells eventually leading to liver failure. However, the question they came up with was how does alcohol activate IRF3 and which pathways are amplified that deliver the disease spread throughout the liver.

"Until now, now we had only few clues about why alcohol-related liver disease progresses the way it does, but this research fills in key pieces of the puzzle," says Patel.

"It is very encouraging to see that we now have evidence-based targets for drug development for ALD," says Luther.

Source: Science Daily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
SEP 21, 2020
Drug Discovery & Development
WHO Endorses Clinical Trials for Herbal Medicines to Treat COVID-19
SEP 21, 2020
WHO Endorses Clinical Trials for Herbal Medicines to Treat COVID-19
The World Health Organization has endorsed a protocol to put African herbal medicines through clinical trials as possibl ...
OCT 14, 2020
Immunology
Self-Healing Microcapsules Make Promising Leukemia Vaccines
OCT 14, 2020
Self-Healing Microcapsules Make Promising Leukemia Vaccines
Leukemia is a cancer affecting tissues in the body that produce blood cells, including the bone marrow and the lymphatic ...
OCT 23, 2020
Drug Discovery & Development
FDA Gives Full Approval to Remdesivir to Treat COVID-19
OCT 23, 2020
FDA Gives Full Approval to Remdesivir to Treat COVID-19
The US Food and Drug Administration (FDA) has approved antiviral drug Remdesivir, sold under the name ‘Velkury&rsq ...
OCT 23, 2020
Drug Discovery & Development
Common Asthmatic Treatments Increase Risk of Bone Fractures
OCT 23, 2020
Common Asthmatic Treatments Increase Risk of Bone Fractures
A study published in the journal Thorax found that taking steroid inhalers or tablets for asthma treatment to control fl ...
NOV 06, 2020
Drug Discovery & Development
Anti-depressant Shows Promise in Treating Childhood Cancer
NOV 06, 2020
Anti-depressant Shows Promise in Treating Childhood Cancer
Researchers from Sweden and the US have found that a commonly prescribed antidepressant may help stop the growth of a ca ...
NOV 15, 2020
Drug Discovery & Development
Drug Stimulates Female Fertility
NOV 15, 2020
Drug Stimulates Female Fertility
A recent drug, MVT-602, was found to stimulate fertility by acting on the natural 'kisspeptin' hormone system in ...
Loading Comments...